Navigation Links
WaferGen to Present at the Ninth Annual Beyond Genome Conference
Date:6/9/2008

FREMONT, Calif., June 9 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that Kumar Kastury, Ph.D., vice president of assay development, will provide a poster presentation on its SmartChip(TM) Real-Time PCR System at the Cambridge Healthcare Institute's Ninth Annual Beyond Genome conference. The conference will be held June 8-11, 2008, at the Fairmont Hotel in San Francisco.

WaferGen's poster presentation will be available on Wednesday, June 11th from 9:50 a.m. until 4:30 p.m. The presentation will include an overview of the company's novel whole genome, high-throughput SmartChip Real-Time PCR System, as well as data related to 100nL real-time PCR gene expression. The SmartChip Real-Time PCR System can perform tens of thousands of nano-scale quantitative PCR (qPCR) assays in a single run, combining the screening throughput of microarrays with the sensitivity of qPCR in a single step.

About WaferGen

WaferGen Biosystems, Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for gene expression, genotyping, cell biology and stem cell research for the life science and pharmaceutical industries. The company is actively developing its SmartChip(TM) product for the gene expression and genotyping markets. SmartChip(TM) is being developed as the first whole genome, high throughput gene expression real-time polymerase chain reaction (PCR) platform and promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets. WaferGen currently markets its SmartSlide(TM) family of products to companies and organizations involved in stem cell and cell biology research. SmartSlide(TM), which was launched in 2006, represents the first fluidics integrated micro-incubators enabling cell biology and stem cell research. Representative SmartSlide(TM) customers include Harvard University, Mayo Clinic, California Institute of Technology (CalTech), Abbott Labs, and the National Institutes of Health (NIH).

Contact:

Vida Communication (on behalf of WaferGen)

Stephanie Diaz (investors) Tim Brons (media)

415-675-7400 415-675-7402

sdiaz@vidacommunication.com tbrons@vidacommunication.com


'/>"/>
SOURCE WaferGen Biosystems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. WaferGen Announces Signing of Two Private Placements
2. WaferGen to Present at the Rodman and Renshaw Fifth Annual Global Healthcare Conference
3. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in Germany
4. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France
5. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
6. WaferGen Announces Management Team Promotions
7. WaferGen to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
8. WaferGen to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
10. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
11. Gen-Probe to Webcast Presentation at Seventh Annual Needham Biotechnology and Medical Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... 2017  Spherix Incorporated (Nasdaq: SPEX ) ... of technology and monetization of intellectual property, today provided ... Anthony Hayes , Chief Executive Officer of ... to communicate with shareholders about the status of existing ... on other patent assets that fit with our current ...
(Date:1/23/2017)... ... January 23, 2017 , ... Calvert Labs, Inc. announced ... and Senior Director, Safety Pharmacology. Dr. Thomas earned his M.Sc. and Ph.D. ... career as an academic and industry preclinical drug developer spans more than three ...
(Date:1/21/2017)... ... January 20, 2017 , ... ... resource to the healthcare industry ( http://www.gandlscientific.com ), has announced the opening of ... of clinical and scientific consultants and contractors. This is the latest step in ...
(Date:1/21/2017)... -- Bioptix, Inc. (Nasdaq: BIOP ... 14, 2017 the Board of Directors of the Company ... certain employees associated with the September 2016 acquisition of ... on January 16, 2017 and terminations are expected to ... severance benefits in certain circumstances of up to one ...
Breaking Biology Technology:
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, ... global financial services provider, today announced an agreement with NuData ... biometrics, to join forces. The partnership will enable clients to ... in compliance with local data protection regulation. ... In order to provide ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
(Date:12/7/2016)... Israel , December 7, 2016 BioCatch ... the expansion of its patent portfolio, which grew to over 40 granted ... , , ... its recently filed patent entitled " System, Device, and Method ... technology that enables device makers to forego costly hardware components needed to ...
Breaking Biology News(10 mins):